跳至主要内容
临床试验/CTRI/2025/06/089106
CTRI/2025/06/089106尚未招募3 期

clinical study to evaluate the efficacy of vasa Pratisarniya kshar in the management of abhyantara arsha w.s.r internal haemorrhoid (1 st and 2nd degree)

Dr Alok Kumar yadav1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2025年5月7日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
45
试验地点
1
主要终点
Reduction in size of pile mass

研究概览

简要总结

Arsha can be defined as dilated plexus of superior haemorrhoidal veins,in relation to

anal canal.Due to indulgence in incompatible food,there is a diminution of agni leading to constipation and vegdharana which leads to pratilomgati of Apana vayu. There are several drugs for Arshas but here I have chosen Pratisarniya kshar which not only treat it’s symptoms but also does samprapti bhanga.

Therefore I have selected 45 patients aged between 30-60 years,patients should be selected on the basis of inclusion and exclusion criteria . The trial will be of 21 days or 3 weeks follow up will be done after every week. Cured after 3rd week patient gets 80-100 percent  from sign and symptoms

研究设计

研究类型
Interventional
分配方式
Other
盲法
Not Applicable

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients having Arsha who are fulfilling my study criteria and who are willing to be selected will be enrolled Patients with 1st and 2nd degree haemorrhoids Patient of the age group above 30 years – below 60 years Patient will be selected irrespective of sex Patients who will be ready to give written consent.

排除标准

  • Patients planning to conceive in near future[during course of trial] Any congenital diseases like haemophillia Patients with 3 degree, 4 degree or prolapsed piles Pregnant women and Lactating mothers Patients suffering from Thrombosed Piles mass,Ulcerative Colitis and CA rectum.

结局指标

主要结局

Reduction in size of pile mass

时间窗: 21 days or 3 week | The trial drug will be given for 3 weeks and follow up will be done after 3rd week

次要结局

  • Bleeding reduced per rectum and relief in burning sensation(After analysing all the parameters the result will be assessed on the basis of symptomatic relief and improvement.)

研究者

发起方
Dr Alok Kumar yadav
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验